» Articles » PMID: 38127900

"I Was Screaming Hallelujah": Patient and Provider Perceptions of Blood-based Testing for Colorectal Cancer Screening

Overview
Journal PLoS One
Date 2023 Dec 21
PMID 38127900
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Blood-based tests for colorectal cancer (CRC) screening can offer many advantages over stool-based tests such as FIT. Yet, we know little about patients' and providers' perceptions of this type of test. We report findings from a qualitative study comparing patient and provider perceptions of blood-based testing for CRC screening.

Methods: Patient participants were aged 45-75 years and members of a large, integrated health system. Participants were mailed, but did not complete, a FIT through an organized FIT-screening program and were scheduled for a health-care encounter at any of nine clinical sites. Participants were consented to complete a blood draw. We used purposive sampling to select and recruit patients (who did and did not complete the blood test) and providers/specialists who would be involved in offering the blood test to patients or explaining results. We administered telephone interviews using a semi-structured interview guide and recorded and transcribed all interviews, then coded and analyzed content.

Results: We interviewed 15 patients (11 completed and 4 did not complete the blood test) and 5 providers (3 primary care providers, one gastroenterologist (GI), and one GI medical assistant). Patients were enthusiastic about completing a blood test, citing the simplicity, ease, convenience, and high perceived accuracy of the test. Providers were also receptive to a blood-based option, if adequate test performance could be achieved and if they have information that informs patients about the pros and cons of blood-based screening versus other screening tests.

Conclusions: Patients and providers were willing and enthusiastic about blood-based CRC screening tests. Future research focusing on performance and communication is needed.

Citing Articles

Cost-Effectiveness of Noninvasive Colorectal Cancer Screening in Community Clinics.

Nascimento de Lima P, Matrajt L, Coronado G, Escaron A, Rutter C JAMA Netw Open. 2025; 8(1):e2454938.

PMID: 39820690 PMC: 11739995. DOI: 10.1001/jamanetworkopen.2024.54938.

References
1.
Lin J, Perdue L, Henrikson N, Bean S, Blasi P . Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021; 325(19):1978-1998. DOI: 10.1001/jama.2021.4417. View

2.
Morse J . Critical Analysis of Strategies for Determining Rigor in Qualitative Inquiry. Qual Health Res. 2015; 25(9):1212-22. DOI: 10.1177/1049732315588501. View

3.
Davis K, Hallman M, Dicarlo M, Wambua S, Jaffe R, Welsh A . Factors Likely to Affect the Uptake of Genomic Approaches to Cancer Screening in Primary Care: A Scoping Review. J Pers Med. 2022; 12(12). PMC: 9785136. DOI: 10.3390/jpm12122044. View

4.
Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

5.
Malla M, Loree J, Kasi P, Parikh A . Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices. J Clin Oncol. 2022; 40(24):2846-2857. PMC: 9390824. DOI: 10.1200/JCO.21.02615. View